EF

Eric Furfine

RP Regeneron Pharmaceuticals: 17 patents #63 of 810Top 8%
VI Vertex Pharmaceuticals Incorporated: 14 patents #152 of 896Top 20%
BS Bristol-Myers Squibb: 8 patents #673 of 3,969Top 20%
GW Glaxo Wellcome: 4 patents #40 of 449Top 9%
GL Glaxosmithkline: 1 patents #290 of 646Top 45%
AS Aventis Pharma S.A.: 1 patents #304 of 591Top 55%
AL Albumedix: 1 patents #12 of 24Top 50%
📍 Lincoln, MA: #8 of 335 inventorsTop 3%
🗺 Massachusetts: #1,154 of 88,656 inventorsTop 2%
Overall (All Time): #52,006 of 4,157,543Top 2%
51
Patents All Time

Issued Patents All Time

Showing 26–50 of 51 patents

Patent #TitleCo-InventorsDate
8802107 VEGF antagonist formulations for intravitreal administration Daniel Dix, Kenneth S. Graham, Kelly Frye 2014-08-12
8728483 Multivalent fibronectin based scaffold domain proteins Ray Camphausen, Irvith M. Carvajal, H. Nicholas Marsh, Marco Gottardis, Joan Carboni +1 more 2014-05-20
8481046 VEGF antagonist formulations for intravitreal administration Daniel Dix, Kenneth S. Graham, Kelly Frye 2013-07-09
8455497 Inhibitors of aspartyl protease Michael Hale, Roger D. Tung, Stephen Price, Robin Wilkes, Wayne C. Schairer +7 more 2013-06-04
8388963 Antitumor combinations containing a VEGF-inhibiting agent and 5FU or a derivative thereof Patricia VRIGNAUD, Marielle CHIRON-BLONDEL, Marie-Christine Bissery, Jocelyn Holash, Jesse M. Cedarbaum 2013-03-05
8221765 Multivalent fibronectin based scaffold domain proteins Ray Camphausen, Irvith M. Carvajal, H. Nicholas Marsh, Marco Gottardis, Joan Carboni +1 more 2012-07-17
8092803 VEGF antagonist formulations for intravitreal administration Daniel Dix, Kenneth S. Graham, Kelly Frye 2012-01-10
7919523 Inhibitors of aspartyl protease Michael Hale, Christopher Baker, Timothy A. Stammers, Ronald George Sherrill, Andrew Spaltenstein +4 more 2011-04-05
7807164 Lyophilized VEGF antagonist formulations for intravitreal administration Daniel Dix, Kenneth S. Graham, Kelly Frye 2010-10-05
7608261 VEGF antagonist formulations suitable for intravitreal administration Daniel Dix, Kenneth S. Graham, Kelly Frye 2009-10-27
7592368 Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors Roger D. Tung, Michael Hale, Christopher Baker, Istvan Kaldor, Wieslaw Mieczylaw Kazmierski +1 more 2009-09-22
7531172 Methods of treating diseases with a VEGF antagonist Neil Stahl, George D. Yancopoulos, Jesse M. Cedarbaum 2009-05-12
7442718 Inhibitors of aspartyl protease Michael Hale, Christopher Baker, Timothy A. Stammers, Ronald George Sherrill, Andrew Spaltenstein +4 more 2008-10-28
7419967 Sulfonamide inhibitors of aspartyl protease Michael Hale, Clarence Webster Andrews, III, Ronald George Sherrill, Andrew Spaltenstein, Gregory T. Lowen 2008-09-02
6878728 Inhibitors of aspartyl protease Michael Hale, Roger D. Tung, Stephen Price, Robin Wilkes, Wayne C. Schairer +6 more 2005-04-12
6838474 Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors Roger D. Tung, Michael Hale, Christopher Baker, Istvan Kaldor, Wieslaw Mieczylaw Kazmierski +1 more 2005-01-04
6811780 Methods of using cytokine antagonists to treat HIV infection and AIDS Neil Stahl 2004-11-02
6617350 Inhibitors of aspartyl protease Michael Hale, Christopher Baker, Timothy A. Stammers, Ronald George Sherrill, Andrew Spaltenstein +4 more 2003-09-09
6613743 Sulfonamide inhibitors of aspartyl protease Michael Hale, Clarence Webster Andrews, III, Ronald George Sherrill, Andrew Spaltenstein, Gregory T. Lowen 2003-09-02
6559137 Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors Roger D. Tung, Michael Hale, Christopher Baker, Istvan Kaldor, Wieslaw Mieczylaw Kazmierski +1 more 2003-05-06
6319946 Inhibitors of aspartyl protease Michael Hale, Christopher Baker, Timothy A. Stammers, Ronald George Sherrill, Andrew Spaltenstein +4 more 2001-11-20
RE37438 Acetamidine derivatives and their use as inhibitors for the nitric oxide synthase Jeffrey Alan Oplinger, Edward Patrick Garvey, Barry George Shearer, Jon Loren Collins 2001-11-06
6297276 Substituted urea and isothiourea derivatives as no synthase inhibitors Jeffrey Alan Oplinger, Barry George Shearer, Eric C. Bigham, Edward Patrick Garvey 2001-10-02
6225305 Substituted urea and isothiorea derivatives as no synthase inhibitors Jeffrey Alan Oplinger, Barry George Shearer, Eric C. Bigham, Edward Patrick Garvey 2001-05-01
6090846 Substituted urea and isothiourea derivatives as no synthase inhibitors Jeffrey Alan Oplinger, Barry George Shearer, Edward Patrick Garvey 2000-07-18